infectious disease

Using bioinformatics and machine learning, scientists probe the depths of fungal genomes to find new compounds for undruggable cancers and infections.

From sea squirts to ants to opossums on the side of the road, the bacteria that live in animal microbiomes are a surprising source of new antifungals.

The history of antibody research has led to modern immunotherapy treatments for infectious diseases.

The recent COVID-19 mRNA vaccines represent a new wave of vaccines based on mRNA technology.

LIVE November 29th, 2021 at 11:00 AM ET
Investigating the pathophysiology and spread of human viruses

Scientists continue to ring alarm bells about the risks associated with the continued misuse of antimicrobials and advocate for innovative treatments, improved surveillance, and greater public health education.

LIVE October 26th, 2021 at 11:00 AM ET
Experts will discuss recent advances in screening strategies to more efficiently identify therapeutic candidates for infectious diseases such as schistosomiasis and COVID-19.

Vaccine development for infectious diseases gives rise to new vaccine approaches and accelerated development and approval timelines.

Investigating antibodies produced by infectious diseases yields vaccines with broad-acting protection.

From microgravity to radiation, space wreaks havoc on astronauts’ immune systems, potentially putting them at risk of infection from microbes onboard.